How does mass spectrometry imaging distinguish cancer tissue from paracancerous tissue?
1. Differential-molecule identification2. Boundary delineation3. Methodological points4. Linkage with spatial omics
1. Differential-molecule identification
Perform full m/z imaging on the same section, measure the intensity of each cancer/paracancerous channel, and screen out spatially specific ions as candidate differential molecules; then return to the tissue in-situ to verify the correspondence between their distribution and the H&E morphology.
This directly connects with biomarker discovery in cancer research.
2. Boundary delineation
The spatial gradient of differential molecules can be used to delineate the invasive boundary, especially for regions with unclear morphology, where the molecular map provides supplementary criteria.
High-resolution sources (such as LDPI 2–3 μm) can characterize boundary heterogeneity at the cellular scale, reducing misjudgment.
3. Methodological points
Histological comparison with the same or adjacent sections is needed, using a defined cancer/paracancerous partition criterion; quantitatively, combine a semi-quantitation/quantitation strategy to report the magnitude of differences.
Avoid drawing conclusions based solely on a single image; repeat and report statistics.
4. Linkage with spatial omics
Cancer/paracancerous differences can be further connected with spatial omics for systematic annotation, forming a closed loop from molecular map to mechanism.
The value of MSI lies in providing locatable and verifiable differential evidence.
Frequently Asked Questions (FAQ)
- How does MSI distinguish cancer from paracancerous?
- Compare the cancer/paracancerous molecular maps, find differential ions and delineate the boundary in-situ.
- Is histological comparison needed?
- Yes, same-section/adjacent-section H&E comparison with fixed partition standards.
- Is high resolution helpful?
- LDPI 2–3 μm can characterize boundary heterogeneity at the cellular scale.
- What is its relationship with cancer biomarkers?
- Differential molecules can serve as candidate biomarkers for in-situ verification.
Get Specifications & Quotation
To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).